DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $207,000 | -98.1% | 679 | -98.6% | 0.04% | -95.6% |
| Q2 2021 | $11,061,000 | -50.0% | 49,144 | -50.0% | 0.97% | -59.9% |
| Q1 2021 | $22,122,000 | +106.4% | 98,288 | +103.7% | 2.42% | -6.1% |
| Q4 2020 | $10,720,000 | -0.4% | 48,259 | -3.5% | 2.57% | -10.4% |
| Q3 2020 | $10,765,000 | -32.5% | 49,993 | -44.5% | 2.87% | -31.4% |
| Q2 2020 | $15,942,000 | +24.0% | 90,153 | -2.9% | 4.18% | +8.9% |
| Q1 2020 | $12,855,000 | -11.1% | 92,875 | -1.4% | 3.84% | -0.5% |
| Q4 2019 | $14,460,000 | +2.8% | 94,211 | -3.3% | 3.86% | -4.3% |
| Q3 2019 | $14,067,000 | -6.8% | 97,396 | -7.8% | 4.04% | -4.8% |
| Q2 2019 | $15,096,000 | +5.5% | 105,624 | -2.6% | 4.24% | +0.4% |
| Q1 2019 | $14,315,000 | +25.7% | 108,433 | -1.8% | 4.22% | +13.3% |
| Q4 2018 | $11,388,000 | -4.9% | 110,430 | +0.2% | 3.73% | +5.2% |
| Q3 2018 | $11,975,000 | +8.2% | 110,209 | -1.7% | 3.54% | +3.6% |
| Q2 2018 | $11,063,000 | -3.4% | 112,114 | -4.1% | 3.42% | -6.1% |
| Q1 2018 | $11,450,000 | +2.6% | 116,939 | -2.7% | 3.64% | +9.7% |
| Q4 2017 | $11,156,000 | +4.1% | 120,186 | -3.8% | 3.32% | +1.0% |
| Q3 2017 | $10,713,000 | +0.7% | 124,893 | -0.9% | 3.29% | +1.4% |
| Q2 2017 | $10,640,000 | -2.1% | 126,082 | -0.8% | 3.24% | -0.5% |
| Q1 2017 | $10,868,000 | +10.2% | 127,065 | +0.3% | 3.26% | +9.9% |
| Q4 2016 | $9,863,000 | -0.8% | 126,707 | -0.1% | 2.96% | -5.5% |
| Q3 2016 | $9,942,000 | -23.8% | 126,824 | -1.8% | 3.14% | -27.6% |
| Q2 2016 | $13,042,000 | +4.4% | 129,133 | -1.9% | 4.33% | +3.7% |
| Q1 2016 | $12,491,000 | +0.2% | 131,680 | -1.9% | 4.18% | +0.6% |
| Q4 2015 | $12,472,000 | +6.1% | 134,284 | -2.6% | 4.15% | +3.9% |
| Q3 2015 | $11,750,000 | -0.3% | 137,891 | +0.1% | 4.00% | +3.3% |
| Q2 2015 | $11,791,000 | -2.0% | 137,766 | -2.8% | 3.87% | +5.1% |
| Q1 2015 | $12,029,000 | -2.8% | 141,685 | -1.9% | 3.68% | -3.3% |
| Q4 2014 | $12,373,000 | -99.9% | 144,364 | -1.4% | 3.81% | +14.6% |
| Q3 2014 | $11,126,283,000 | +96650.3% | 146,437 | +0.2% | 3.32% | +0.8% |
| Q2 2014 | $11,500,000 | +4.2% | 146,072 | -0.8% | 3.30% | +5.7% |
| Q1 2014 | $11,040,000 | -3.2% | 147,198 | -0.4% | 3.12% | -4.9% |
| Q4 2013 | $11,405,000 | +9.4% | 147,732 | -1.8% | 3.28% | +15.5% |
| Q3 2013 | $10,427,000 | +7.5% | 150,419 | -1.8% | 2.84% | +6.6% |
| Q2 2013 | $9,698,000 | – | 153,201 | – | 2.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |